Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000613

Options or other derivatives

  • Chief Medical Officer acquired 69,142 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schmidt William K Chief Medical Officer 2021-06-30 Grant or award · Stock Option +69,142 69,142 D: show line 1 in the form
Loading xslF345X03/edgar.xml…